REIMBURSEMENT CLINIC: Killing two birds with one stone
This article was originally published in Clinica
Executive Summary
In Clinica’s new reimbursement Q&A series, Dr Mark Charny of UK consultancy Translucency discusses how careful strategizing can help companies fulfil evidential needs for both regulatory approval and reimbursement while avoiding costly mistakes